With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Marble Falls, Texas - New telemedicine solution offers accessible, personalized weight management. Victory Select, the ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

to ensure that they are ready to seek out and commit to GLP-1 therapy — and continue to have the emotional, mental, and even socioeconomic capacity to stay on medication for the long haul.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...